Srikanth Nama

867 total citations
16 papers, 542 citations indexed

About

Srikanth Nama is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Srikanth Nama has authored 16 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Srikanth Nama's work include Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). Srikanth Nama is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). Srikanth Nama collaborates with scholars based in Singapore, India and Denmark. Srikanth Nama's co-authors include Prabha Sampath, Vivek Tanavde, Gopinath M. Sundaram, Manish Muhuri, Vladimir A. Kuznetsov, Ghim Siong Ow, Candida Vaz, Norihiro Tsuneyoshi, N. Ray Dunn and Iwona Szczerbinska and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and Development.

In The Last Decade

Srikanth Nama

16 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srikanth Nama Singapore 11 356 191 105 99 82 16 542
Xufang Dai China 14 434 1.2× 148 0.8× 34 0.3× 25 0.3× 17 0.2× 27 651
Jian Fu China 11 261 0.7× 96 0.5× 16 0.2× 30 0.3× 64 0.8× 19 431
Duane Currier United States 10 325 0.9× 69 0.4× 31 0.3× 16 0.2× 24 0.3× 13 551
Ana C. Millena United States 8 267 0.8× 105 0.5× 50 0.5× 29 0.3× 15 0.2× 8 449
Elsa Romero United States 13 297 0.8× 39 0.2× 42 0.4× 50 0.5× 58 0.7× 16 518
Aya Nonaka Japan 7 451 1.3× 99 0.5× 12 0.1× 40 0.4× 51 0.6× 9 622
Shiaw‐Wei Tyan Taiwan 8 255 0.7× 76 0.4× 41 0.4× 20 0.2× 28 0.3× 8 427
Loïc Van Den Berghe France 13 275 0.8× 42 0.2× 82 0.8× 80 0.8× 54 0.7× 21 461
Jean-Pierre Roperch France 9 335 0.9× 71 0.4× 22 0.2× 75 0.8× 56 0.7× 10 503
Yunyun Jin China 12 251 0.7× 38 0.2× 40 0.4× 38 0.4× 45 0.5× 16 476

Countries citing papers authored by Srikanth Nama

Since Specialization
Citations

This map shows the geographic impact of Srikanth Nama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikanth Nama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikanth Nama more than expected).

Fields of papers citing papers by Srikanth Nama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srikanth Nama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikanth Nama. The network helps show where Srikanth Nama may publish in the future.

Co-authorship network of co-authors of Srikanth Nama

This figure shows the co-authorship network connecting the top 25 collaborators of Srikanth Nama. A scholar is included among the top collaborators of Srikanth Nama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srikanth Nama. Srikanth Nama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Utami, Kagistia Hana, Marta Garcia‐Miralles, Niels H. Skotte, et al.. (2023). Dysregulated COMT Expression in Fragile X Syndrome. NeuroMolecular Medicine. 25(4). 644–649. 1 indexed citations
2.
Utami, Kagistia Hana, Niels H. Skotte, Ana R. Colaço, et al.. (2020). Integrative Analysis Identifies Key Molecular Signatures Underlying Neurodevelopmental Deficits in Fragile X Syndrome. Biological Psychiatry. 88(6). 500–511. 32 indexed citations
3.
Nama, Srikanth, Manish Muhuri, Shan Quah, et al.. (2019). MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression. Scientific Reports. 9(1). 12718–12718. 39 indexed citations
4.
Winata, Cecilia Lanny, Leszek P. Pryszcz, Candida Vaz, et al.. (2018). Cytoplasmic polyadenylation-mediated translational control of maternal mRNAs directs maternal-to-zygotic transition. Development. 145(1). 44 indexed citations
5.
Sundaram, Gopinath M., Mohsin Bashir, Manish Muhuri, et al.. (2017). EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis. The Journal of Experimental Medicine. 214(10). 2889–2900. 53 indexed citations
6.
Nama, Srikanth, Manish Muhuri, Shan Quah, et al.. (2017). C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas. Nucleic Acids Research. 46(1). 336–349. 17 indexed citations
7.
Giannakakis, Antonis, Jingxian Zhang, Piroon Jenjaroenpun, et al.. (2015). Contrasting expression patterns of coding and noncoding parts of the human genome upon oxidative stress. Scientific Reports. 5(1). 9737–9737. 55 indexed citations
8.
Qu, Jing, Rya Ero, L.S. Ong, et al.. (2015). Kindlin-3 interacts with the ribosome and regulates c-Myc expression required for proliferation of chronic myeloid leukemia cells. Scientific Reports. 5(1). 18491–18491. 14 indexed citations
9.
Ho, Lena, Shawn Y.X. Tan, Sheena Wee, et al.. (2015). ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell stem cell. 17(4). 435–447. 145 indexed citations
10.
Ho, Lena, Shawn Y.X. Tan, Sheena Wee, et al.. (2015). ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell stem cell. 17(5). 635–635. 10 indexed citations
11.
Nama, Srikanth, Pamela Rizk, Srinivas Ramasamy, et al.. (2012). Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas. Cell Reports. 2(3). 591–602. 84 indexed citations
12.
Nama, Srikanth, et al.. (2012). LC/MS:AN ESSENTIAL TOOL IN DRUG DEVELOPMENT. Scholar Science Journals - International Journal of Biomedical Research. 1(2). 2 indexed citations
13.
Nama, Srikanth, et al.. (2012). LC/MS:AN ESSENTIAL TOOL IN DRUG DEVELOPMENT. 1(2). 1 indexed citations
14.
Nama, Srikanth, et al.. (2011). Development and Validation of a New RP-HPLC Method for the Determination of Aprepitant in Solid Dosage Forms. Tropical Journal of Pharmaceutical Research. 10(4). 7 indexed citations
15.
Kothari, Vishal, et al.. (2009). HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus‐HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model. International Journal of Cancer. 126(3). 733–742. 15 indexed citations
16.
Das, Sanjeev, et al.. (2005). p73β-expressing recombinant adenovirus: a potential anticancer agent. Cancer Gene Therapy. 12(4). 417–426. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026